COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,141 Articles (22,693 medRxiv, 8,448 bioRxiv)

Most recent first Previous |  Page 186: Articles 1851-1860  | Next

Deep generative models generate mRNA sequences with enhanced translation capacity and stability
Zhang, H., Liu, H., Xu, Y., Liu, Y., Wang, J., Qin, Y., Wang, H., Ma, L., Xun, Z., Lu, T. K., Cao, J.
10.1101/2024.06.20.599727 — Posted: 2024-06-20
Next Generation Aging Clock: A Novel Approach to Decoding Human Aging Through Over 3000 Cellular Pathways
Xiong, J.
10.1101/2024.06.18.599632 — Posted: 2024-06-20
The Integration of Health Equity into Policy to Reduce Disparities: Lessons from California during the COVID-19 Pandemic
Kwan, A. T., Vargo, J., Kurtz, C., Panditrao, M., Hoover, C. M., Leon, T. M., Rocha, D., Wheeler, W., Jain, S., Pan, E. S., Shete, P. B.
10.1101/2024.06.18.24308793 — Posted: 2024-06-19
A causal link between autoantibodies and neurological symptoms in long COVID
Santos Guedes de Sa, K., Silva, J., Bayarri-Olmos, R., Brinda, R., Alec Rath Constable, R., A. Colom Diaz, P., Kwon, D.-i., Rodrigues, G., Wenxue, L., Baker, C., Bhattacharjee, B., Wood, J., Tabacof, L., Liu, Y., Putrino, D., L. Horvath, T., Iwasaki, A.
10.1101/2024.06.18.24309100 — Posted: 2024-06-19
The role of socio-economic determinants in SARS-CoV-2 health outcomes: systematic review of population-based studies.
Ghattas, J., Makovski, T., Monnier-Besnard, S., Cavillot, L., Ambrozova, M., Budikova, B., Feteira-Santos, R., Bezzegh, P., Ponce Bollmann, F., Cottam, J., Haneef, R., Speybroeck, N., Nogueira, P. J., Forjaz, M. J., Coste, J., Carcaillon-bentata, L., Devleesschauwer, B.
10.1101/2024.06.18.24309062 — Posted: 2024-06-19
Anti-Nucleocapsid and Anti-Spike Antibody Trajectories in People with Post-Covid Condition versus Acute-Only Infections: Results from the Virus Watch Prospective Cohort Study
Beale, S., Yavlinsky, A., Moncunill, G., Fong, W. L. E., Nguyen, V., Kovar, J., Hayward, A., Abubakar, I., Aldridge, R.
10.1101/2024.06.19.24309147 — Posted: 2024-06-19
Infection control strategies in essential industries: using COVID-19 in the food industry to model economic and public health trade-offs
Henry, C., Bulut, E., Murphy, S. I., Zoellner, C., Adalja, A., Wetherington, D., Wiedmann, M., Alcaine, S., Ivanek, R.
10.1101/2024.06.18.24309041 — Posted: 2024-06-19
Sex differences and immune correlates of Long COVID development, persistence, and resolution
Hamlin, R. E., Pienkos, S. M., Chan, L., Stabile, M. A., Pinedo, K., Rao, M., Grant, P., Bonilla, H., Holubar, M., Singh, U., Jacobson, K. B., Jagannathan, P., Maldonado, Y., Holmes, S. P., Subramanian, A., Blish, C. A.
10.1101/2024.06.18.599612 — Posted: 2024-06-19
A Spike Trimer Dimer-Inducing Nanobody with Anti-Sarbecovirus Activity
Swart, I. C., Debski Antoniak, O. J., Zegar, A., de Bouter, T., Chatziandreou, M., van den Berg, M., Drulyte, I., Pyrc, K., de Haan, C. A. M., Hurdiss, D. L., Bosch, B.-J., Oliveira, S.
10.1101/2024.06.19.598823 — Posted: 2024-06-19
The effect of circulating neutralizing antibodies on the replication of SARS-CoV-2 variants following post-vaccination infections.
Knight, M. A. G., Kelly, J. D., Lu, S., Tassetto, M. A., Goldberg, S. A., Zhang, A., Pineda-Ramirez, J., Anglin, K., Davidson, M., Chen, J. Y., Fortes-Cobby, M., Park, S., Martinez, A., So, M., Donovan, A., Viswanathan, B., Richardson, E. T., McIlwain, D. R., Gaudilliere, B., Rutishauser, R. L., Chenna, A., Petropoulos, C., Wrin, T., Deeks, S., Abedi, G., Saydah, S., Martin, J., Briggs-Hagen, M., Midgley, C. M., Peluso, M., Andino, R.
10.1101/2024.06.18.599357 — Posted: 2024-06-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).